# Topical 0.5% Ivermectin Cream for Treatment of Demodicidosis

> **NCT02036229** · PHASE3 · UNKNOWN · sponsor: **Rabin Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Demodicidosis
- Rosacea

## Interventions

- **DRUG:** ivermectin cream 0.5%

## Key facts

- **NCT ID:** NCT02036229
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2015-12
- **Final completion:** 2016-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2015-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02036229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02036229, "Topical 0.5% Ivermectin Cream for Treatment of Demodicidosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02036229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*